Rationalizing rules for immunotherapy combination trials: About time for precision immunotherapy is a research paper published in Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01CA242845
National Cancer Institute
Grant: R01CA273168
Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
Grant: 1U01 CA180964
NCATS NIH HHS
Grant: UL1 TR000371
NCI NIH HHS
Grant: P30 CA016672
FWCI
0.84
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals